These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 19457162)
1. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP. Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162 [TBL] [Abstract][Full Text] [Related]
2. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003 [TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression. Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948 [TBL] [Abstract][Full Text] [Related]
4. Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells. Joo SH; Kwon KJ; Kim JW; Kim JW; Hasan MR; Lee HJ; Han SH; Shin CY Neurosci Lett; 2010 Jan; 469(3):352-6. PubMed ID: 20026244 [TBL] [Abstract][Full Text] [Related]
5. Generation of a alpha-synuclein-based rat model of Parkinson's disease. Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315 [TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. Lee EJ; Woo MS; Moon PG; Baek MC; Choi IY; Kim WK; Junn E; Kim HS J Immunol; 2010 Jul; 185(1):615-23. PubMed ID: 20511551 [TBL] [Abstract][Full Text] [Related]
7. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease. Park JY; Paik SR; Jou I; Park SM Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945 [TBL] [Abstract][Full Text] [Related]
8. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease. Thomas MP; Chartrand K; Reynolds A; Vitvitsky V; Banerjee R; Gendelman HE J Neurochem; 2007 Jan; 100(2):503-19. PubMed ID: 17241161 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987 [TBL] [Abstract][Full Text] [Related]
10. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease. Kim S; Moon M; Park S J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related]
13. The influence of microglia on the pathogenesis of Parkinson's disease. Long-Smith CM; Sullivan AM; Nolan YM Prog Neurobiol; 2009 Nov; 89(3):277-87. PubMed ID: 19686799 [TBL] [Abstract][Full Text] [Related]
14. Microglial precursors derived from mouse embryonic stem cells. Napoli I; Kierdorf K; Neumann H Glia; 2009 Nov; 57(15):1660-71. PubMed ID: 19455585 [TBL] [Abstract][Full Text] [Related]
15. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569 [TBL] [Abstract][Full Text] [Related]
16. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease. Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878 [TBL] [Abstract][Full Text] [Related]
17. The role of Galectin-3 in α-synuclein-induced microglial activation. Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690 [TBL] [Abstract][Full Text] [Related]
18. Identification of proteins involved in microglial endocytosis of alpha-synuclein. Liu J; Zhou Y; Wang Y; Fong H; Murray TM; Zhang J J Proteome Res; 2007 Sep; 6(9):3614-27. PubMed ID: 17676786 [TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of α-synuclein affects the migration of neural stem cells in mouse subventricular zone. Tani M; Hayakawa H; Yasuda T; Nihira T; Hattori N; Mizuno Y; Mochizuki H J Neurochem; 2010 Nov; 115(4):854-63. PubMed ID: 20374434 [TBL] [Abstract][Full Text] [Related]